Apollo Hospitals Enterprise Limited has announced plans to add 850 new hospital beds during the current financial year as part of its aggressive long-term expansion strategy, with the overall development pipeline now reaching approximately 4,400 beds across India. The expansion comes amid growing healthcare demand, improved occupancy levels, rising overseas patient inflows, and profitability in its consumer healthcare business segment.

Speaking on the company’s growth roadmap, Managing Director Suneeta Reddy said the hospital network is witnessing strong momentum across inpatient care, digital health, pharmacy operations, and international medical tourism, supporting Apollo’s next phase of capacity expansion. The new beds will be added across both brownfield and greenfield projects in key metropolitan and Tier-II cities.

Apollo Hospitals currently operates more than 10,000 beds across over 70 hospitals nationwide, making it one of India’s largest integrated healthcare providers. The company plans to invest nearly INR 6,000 crore over the next four to five years to strengthen tertiary and quaternary healthcare infrastructure while expanding specialty care services including oncology, cardiology, neurology, and organ transplantation.

According to company estimates, around 2,000 beds from the total 4,400-bed pipeline are already under various stages of development and are expected to become operational progressively over the next few years. The expansion is aimed at meeting rising patient volumes as India’s healthcare sector continues to experience strong post pandemic growth.

Apollo Hospitals also reported increasing international patient inflows, particularly from South Asia, the Middle East, and Africa. Medical tourism remains a major growth driver for Indian hospital chains, with India’s medical value travel market projected to reach nearly USD 13 billion by 2026, according to industry estimates. The company noted that complex surgeries, oncology treatments, robotic procedures, and organ transplants are witnessing particularly high demand from overseas patients.

The healthcare major’s consumer healthcare and pharmacy business has also turned profitable, contributing positively to consolidated performance. Apollo’s digital health platform and omnichannel pharmacy network continue to expand rapidly, supported by rising adoption of telemedicine, e-pharmacy services, and preventive healthcare solutions.

Industry analysts believe Apollo’s accelerated bed expansion strategy reflects increasing confidence in India’s long-term healthcare demand outlook, driven by rising chronic disease burden, expanding insurance penetration, higher healthcare spending, and growing demand for advanced specialty treatment infrastructure across urban and semi

urban markets.